-
Jan 1998
HLA-DR class II associations with rubella vaccine-induced joint manifestations.
J Infect DisMitchell LA, Tingle AJ, MacWilliam L, Horne C, Keown P, Gaur LK, Nepom GT -
Jan 1998
Major histocompatibility complex-directed susceptibility to rheumatoid arthritis.
Adv ImmunolNepom GT -
Aug 1997
High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
J AutoimmunBach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM -
Jul 1997
Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
J Clin InvestMuraro PA, Vergelli M, Kalbus M, Banks DE, Nagle JW, Tranquill LR, Nepom GT, Biddison WE, McFarland HF, Martin R -
Jul 1997
Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis.
Arthritis RheumPenzotti JE, Nepom GT, Lybrand TP -
Jul 1997
Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.
J Clin InvestHershberg RM, Framson PE, Cho DH, Lee LY, Kovats S, Beitz J, Blum JS, Nepom GT -
Apr 1997
Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein.
VaccineNepom GT, Domeier ME, Ou D, Kovats S, Mitchell LA, Tingle AJ -
Apr 1997
MHC-DRB allelic sequences incorporate distinct intragenic trans-specific segments.
Tissue AntigensGaur LK, Nepom GT, Snyder KE, Anderson J, Pandarpurkar M, Yadock W, Heise ER -
Apr 1997
Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201.
Hum ImmunolKoelle DM, Johnson ML, Ekstrom AN, Byers P, Kwok WW -
Dec 1996
Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
J Clin InvestWicker LS, Chen SL, Nepom GT, Elliott JF, Freed DC, Bansal A, Zheng S, Herman A, Lernmark A, Zaller DM, Peterson LB, Rothbard JB, Cummings R, Whiteley PJ -
Dec 1996
CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles.
J ImmunolChapman A, Stewart SJ, Nepom GT, Green WF, Crowe D, Thomas JW, Miller GG -
Dec 1996
Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions.
J ImmunolBuckner JH, Kwok WW, Nepom BS, Nepom GT -
Oct 1996
Characterization of the HLA-restrictive elements of a rubella virus-specific cytotoxic T cell clone: influence of HLA-DR4 beta chain residue 74 polymorphism on antigenic peptide-T cell interaction.
Int ImmunolOu D, Mitchell LA, Domeier ME, Tsang AO, Décarie D, Tingle AJ, Nepom GT, Lacroix M, Zrein M -
Jul 1996
Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules.
Proc Natl Acad Sci U S ANepom BS, Nepom GT, Coleman M, Kwok WW -
May 1996
Ancestral major histocompatibility complex DRB genes beget conserved patterns of localized polymorphisms.
Proc Natl Acad Sci U S AGaur LK, Nepom GT